Chiron Real Estate Inc. · NYSE:XRN
Chiron Real Estate — Global Medical REIT — Q3 2025 Earnings Presentation
24 slides from Chiron Real Estate's earnings presentation, Nov 5, 2025
Slide 1: Third Quarter 2025 Earnings Supplemental
St. Joseph’s Medical Plaza – Tucson, AZ THIRD QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE
Slide 2: Table of Contents
TABLE OF CONTENTS Company Overview 3 Select Quarterly Financial Data 6 Business Summary 7 Acquisitions / Dispositions 8 Portfolio Summary 9 Key Tenants 11 Debt and Hedging Summary 12 Total Capitalization and Equity 14 Summary Condensed Consolidated 15 Statements of Operations Condensed Consolidated
Slide 3: Company Overview
COMPANY OVERVIEW GLOBAL MEDICAL REIT INC. (GMRE) IS A NET-LEASE MEDICAL REAL ESTATE INVESTMENT TRUST (REIT) THAT ACQUIRES HEALTHCARE FACILITIES AND LEASES THOSE FACILITIES TO PHYSICIAN GROUPS AND REGIONAL AND NATIONAL HEALTHCARE SYSTEMS. Blue Sky Vision – Grand Rapids, MI PORTFOLIO SNAPSHOT (as of S
Slide 4: Company Overview
COMPANY OVERVIEW Executive Officers Mark Decker, Jr. Chief Executive Officer and President Robert Kiernan Chief Financial Officer and Treasurer Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Jamie Barber General Counsel and Corporate Secretary Board of Directors Jeffrey
Slide 5: Company Overview
COMPANY OVERVIEW Corporate Headquarters Global Medical REIT Inc. 7373 Wisconsin Avenue, Suite 800 Sell-Side Analyst Coverage Bethesda, MD 20814 Phone: 202.524.6851 www.globalmedicalreit.com Firm Name Stock Exchange Alliance Global Partners Guarav Mehta New York Stock Exchange Ticker: GMRE B Riley Jo
Slide 6: Select Quarterly Financial Data
SELECT QUARTERLY FINANCIAL DATA (1) (unaudited, and in thousands, except per share and unit amounts) September 30, June 30, March 31, December 31, September 30, As of Period End (Unless Otherwise Specified) 2025 2025 2025 2024 2024 Market capitalization (common and OP) $466,917 $479,036 $604,844 $53
Slide 7: Business Summary
BUSINESS SUMMARY THIRD QUARTER 2025 OPERATING SUMMARY(1) • Net loss attributable to common stockholders was $6.0 million, or $0.45 per diluted share, as compared to net income of $1.8 million, or $0.14 per diluted share, in the comparable prior year period. The current quarter net loss primarily res
Slide 8: Acquisitions / Dispositions
ACQUISITIONS / DISPOSITIONS (as of November 3, 2025) 2025 Acquisitions Completed To-Date Leasable Contractual Annualized Acquisition Square Purchase Price Base Rent* Capitalization Date Property City, State Feet (in thousands) (in thousands) Rate* 2/7/2025 St. Joseph's Medical Plaza Tucson, AZ 95,59
Slide 9: Portfolio Summary
PORTFOLIO SUMMARY (as of September 30, 2025) Texas Digestive Disease Consultants– Ft. Worth, TX PORTFOLIO STATISTICS St Joesph’s Medical Plaza – Tucson, AZ Gross Investment in Real Estate (in billions) $1.5 Total Buildings 191 Total Leasable Square Feet (in millions) 5.2 Total Tenants 315 Leased Occ
Slide 10: Portfolio Summary
PORTFOLIO SUMMARY (as of September 30, 2025) Lease Expiration Schedule (ABR in thousands) Leasable % of Total Leasable % of Total Year # of Leases Square Feet Square Feet ABR* ABR* 2025 8 30,350 0.6% $570 0.5% 2026 84 607,385 11.7% $13,178 11.1% 2027 60 547,586 10.6% $12,625 10.7% 2028 55 303,583 5.
Slide 11: Key Tenants
KEY TENANTS Asset Type % of Portfolio ABR* LifePoint Health operates 60 community hospital campuses, more than 60 rehabilitation and behavioral health hospitals and more than 250 additional sites of IRF 6.8% care, including managed acute rehabilitation units, outpatient centers and post-acute care f
Slide 12: Debt and Hedging Summary
DEBT AND HEDGING SUMMARY As of Pro-Forma As of Debt Statistics (1) September 30, 2025 October 8, 2025 Total Gross Debt (in thousands) $712,853 Fixed Rate Debt-to-Total Debt 70% Weighted Average Interest Rate 4.06% 3.96% Weighted Average Maturity 1.3 years 4.4 years Leverage Ratio* 47.3% Fixed Charge
Slide 13: Debt and Hedging Summary
DEBT AND HEDGING SUMMARY (1) Interest Rate Swap Detail Fixed Effective Notional (in thousands) Term Base Rate Interest Rate Citrus Valley Medical Associates – Corona, CA As of September 30, 2025 (2) Term Loan A - $350,000 Current – April 2026 1.36% 2.95% Term Loan B - $150,000 Current – February 202
Slide 14: Total Capitalization and Equity Summary
TOTAL CAPITALIZATION AND EQUITY SUMMARY (unaudited, and in thousands, except per share data) Total Capitalization As of September 30, 2025 Total Gross Debt $712,853 Preferred Stock $74,959 Common Stock (13,407 shares)(1) $451,950 OP Units (444 units)(1) $14,967 Vested LTIP Units (544 units)(2) $— To
Slide 15: Condensed Consolidated Statements of Operations
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited, and in thousands, except per share amounts) Three Months Ended Nine Months Ended September 30, September 30, 2025 2024 2025 2024 Revenue Rental revenue $ 37,036 $ 34,175 $ 109,510 $ 103,458 Other income 193 89 306 166 Total revenue 37,229 3
Slide 16: Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited, and in thousands) As of September 30, 2025 December 31, 2024 Assets Investment in real estate: Land $ 171,349 $ 174,300 Building 1,087,622 1,044,019 Site improvements 25,065 23,973 Tenant improvements 79,979 69,679 Acquired lease intangible assets 14
Slide 17: Condensed Consolidated Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited, and in thousands) Nine Months Ended September 30, 2025 2024 Operating activities Net (loss) income $ (736) $ 3,753 Adjustments to reconcile net (loss) income to net cash provided by operating activities: Depreciation expense 32,827 30,233 A
Slide 18: Non-GAAP Reconciliations - FFO / AFFO / FAD
NON-GAAP RECONCILIATIONS - FFO / AFFO / FAD* (unaudited, and in thousands, except per share and unit amounts) Three Months Ended September 30, June 30, March 31, December 31, September 30, FFO and AFFO 2025 2025 2025 2024 2024 Net (loss) income $ (5,058) $ 585 $ 3,737 $ 2,939 $ 3,391 Less: Preferred
Slide 19: Non-GAAP Reconciliations - EBITDAre / Adjusted EBITDAre
NON-GAAP RECONCILATIONS – EBITDAre / ADJUSTED EBITDAre* (unaudited, and in thousands, except per share and unit amounts) Three Months Ended September 30, June 30, March 31, December 31, September 30, EBITDAre and Adjusted EBITDAre 2025 2025 2025 2024 2024 Net (loss) income $ (5,058) $ 585 $ 3,737 $
Slide 20: Non-GAAP Reconciliations - Same-Store Cash NOI
NON-GAAP RECONCILATIONS – SAME-STORE CASH NOI* (unaudited, and in thousands, except per share and unit amounts) Three Months Ended September 30, June 30, March 31, December 31, September 30, Same-Store Cash NOI 2025 2025 2025 2024 2024 Net (loss) income $ (5,058) $ 585 $ 3,737 $ 2,939 $ 3,391 Genera
Slide 21: Reporting Definitions and Other Disclosures
REPORTING DEFINITIONS AND OTHER DISCLOSURES Annualized Base Rent Annualized base rent represents monthly base rent for September 2025 (or, for recent acquisitions, monthly base rent for the month of acquisition), multiplied by 12 (or base rent net of annualized expenses for properties with gross lea
Slide 22: Reporting Definitions and Other Disclosures
REPORTING DEFINITIONS AND OTHER DISCLOSURES Earnings Before Interest, Taxes, Depreciation and Amortization for Real Estate (“EBITDAre” and “Adjusted EBITDAre”) We calculate EBITDAre in accordance with standards established by NAREIT and define EBITDAre as net income or loss computed in accordance wi
Slide 23: Reporting Definitions and Other Disclosures
REPORTING DEFINITIONS AND OTHER DISCLOSURES Additional Information The information in this document should be read in conjunction with the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other information filed with, or furnished to, the SEC. Yo
Slide 24: Investor Relations
INVESTOR RELATIONS Contact: investors@globalmedicalreit.com 202.524.6869 globalmedicalreit.com NYSE: GMRE